Veselovskaya N. N.^{1, 2}, Zherebko I. B.^{1, 2}

¹Kyiv Medical University of UAFM, Kyiv, Ukraine
²Kyiv City Ophthalmologic Center, Kyiv City Clinical Hospital no. 1, Kyiv, Ukraine 

 Summary. The information according the comparative effect of eye drops of indomethacine and dexamethasone in diabetic patients are limited.

 Purpose. To compare the clinical efficacy of eye drops of indomethacin and corticosteroid after phacoemulsification with IOL implantation in diabetes type I.

Material and methods. The study involved 28 women (28 eyes) aged 35–65 years with diabetes mellitus type I which during 30 days after cataract surgery used eye drops indocollyre 0.1 % (14 patients) and often dexamethasone 0.1 % (14 patients). Evaluation of the subjective and objective signs of intraocular inflammation and complications, intraocular pressure, intraocular bleeding and blood sugar. 

 Results. The data demonstrated the sufficient efficacy of eye drops of indocollyre 0.1 % with minimal negative influence on the blood sugar level during all period of follow up. That allows us to recommend them after cataract surgery diabetic patients like more preferable drug.

 Keywords: indocollyre 0.1 %, dexamethasone, diabetes, cataract, phacoemulsification, glycemia.

REFERENCES

1. Balashevich L. I., Izmaylov A. S. Cataract in diabetic patients. Classification and rate. Rossiyskaya oftalmologiya onlayn [Russian ophthalmology online]. 2013; (10). Available at www. eyepress.ru/article.aspx?11496 (in Russian).
2. Dzhuraev Zh. A. Application of some NSAIDs in the treatment of postoperative inflammation (Master’s thesis), Tashkent, 2012, 75 p. (in Russian).
3. Yerichev V. P., Filippova O. M. The first experience of the new non-steroidal anti-inflammatory drug indokollira. Glaukoma [Glaucoma]. 2003; (3): 35–36 (in Russian).
4. Isakova I. A. Quality of life in patients with cataract (Author’s abstract), Volgograd, 2010, 27 p. (in Russian).
5. Malyutina I. S., Pogorelova V. V., Yefmova I. A., Kharchenko Ye. G. Comparative evaluation of the effectiveness of dexamethasone 0.1 % and 0.1 % diclofenac sodium for the prevention of inflammatory complications after cataract phacoemulsification. Klinicheskaya oftalmologiya [Clinical ophthalmology]. 2009; (3): 73–75 (in Russian).
6. Rozukulov V. U. Improving surgical treatment of diabetic cataract (Author’s abstract), Tashkent, 2011, 21 р. (in Russian).
7. Petrunya A. M., Garkavenko O. N. The effectiveness of indokollir in electrophoresis with exudative reaction after phacoemulsification with IOL implantation. Suchasni medychni tekhnolohii [Modern medical technology]. 2012; (2): 223–225 (in Russian).
8. Sidikov Zh. Z. During postoperative cataract extraction in patients with the metabolic syndrome (Author’s abstract), Tashkent, 2010, 21 р. (in Russian).
9. Beuerman R. Biomarkers of Ocular Surface Inflammation. Proceedings of the World Ophthalmology Congress 2010 “See you”. Barcelona, 2010, р. 98.
10. Bonini S. Introduction: Inflammation as a Risk Factor for Anterior Segment Surgery. Proceedings of the World Ophthalmology Congress 2010 “See you”. Barcelona, 2010, р. 80.
11. Herbort C. P., Jauch A., Othenin-Girard P., Tritten J. J., Fsadni M. Diclofenac drops to treat inflammation after cataract surgery. Acta Ophthalmol Scand. 2000; (78): 421–424.
12. Thaller V. T., Kulshrestha M. K., Bell K. The effect of pre-operative topical flurbiprofen or diclofenac on pupil dilatation. Eye. 2000; (14): 642–645.

Received: 27 May 2016

Published: December 2016